The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because the mission is to support industry-wide success, Bio presents a broad and unbiased view of investment opportunities.
Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.
The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.
ApolloDx CEO Jared Bauer will be participating in this years conference on the Digital Health panel.
The 2016 19th Annual Bio Conference will be held February 13-14 at the Waldorf Astoria New York.
For questions regarding the digital health discussion please contact firstname.lastname@example.org